Goserelin
Based on 2 publication(s) in Google Scholar
Goserelin (ICI 118630), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer.
For research use only. We do not sell to patients.
- CAS No.: 65807-02-5
- Formula: C59H84N18O14
- Molecular Weight:1269.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Goserelin
More
Biological Activity
GnRH[1]
Goserelin (1 nM-1 mM; 48-72 hours) promots EOC cell apoptosis[1].
Goserelin (100 μM; 24-72 hours) regulates the expression of human apoptosis-related genes in SKOV3-ip cells[1].
Goserelin (100 μM; 24-72 hours) influences EOC cell apoptosis by upregulating FOXO1 through the PI3K/AKT signaling pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)
-
Concentration:1 nM, 10 nM, 100 nM, 1 μM, 10 μM, 100 μM, 1 mM
-
Incubation Time:48 hours, 72 hours
-
Result:Significantly increased the total apoptosis rate of SKOV3-ip, SKOV3 and A2780 cells.
-
Cell Line:SKOV3 cells, SKOV3-ip cells, A2780 cells (human EOC cell lines)
-
Concentration:1 nM, 10 nM, 100 nM, 1μM , 10 μM, 100 μM, 1 mM
-
Incubation Time:48 hours, 72 hours
-
Result:The expression of cleaved-caspase-3 and cleaved-PARP were observably increased at 100 μM.
-
Cell Line:SKOV3-ip cells
-
Concentration:100 μM
-
Incubation Time:24 hours, 48 hours, 72 hours
-
Result:Expression of human apoptosis-related genes regulated
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Five-week-old specific-pathogen free (SPF) female nude mice (18-20 g), subcutaneous xenograft tumor model[1]
-
Dosage:100 µg/mice
-
Administration:Subcutaneous injection, daily, for 19 days
-
Result:Significantly increased the proportion of apoptotic cells in the subcutaneous xenograft tumors
Chemical Information
-
CAS No. 65807-02-5
-
Molecular Weight 1269.41
-
Formula C59H84N18O14
-
Synonyms
ICI 118630
-
Sequence
{Glp}-His-Trp-Ser-Tyr-Ser(OtBu)-Leu-Arg-Pro-{Hydrazinecarboxamide}
-
Sequence Shortening
{Glp}-HWSY-Ser(OtBu)-LRP-{Hydrazinecarboxamide}
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Environ Sci Technol
A Novel Screening Framework Integrating a Two-Cell Assay System and Computational Toxicology to Identify Disruptors of the GnRH Neuron-Gonadotrope Axis. [Abstract]2026 Apr 7;60(13):9881-9894. PMID: 41872703 -
Commun Biol
Diurnal testosterone oscillations gate drug delivery via phase separation of ZO-1 at the blood-testis barrier in mice. [Abstract]2026 Jun 1. PMID: 42219451
Purity & Documentation
References
[1]. Ning Zhang, et al. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway. Oncol Rep. 2018 Mar; 39(3): 1034–1042. [Content Brief]
[2]. Halle C F Moore, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 Mar 5;372(10):923-32. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Goserelin Related Classifications
HY-13673 Related Classifications
Powered by Bioz